Bausch Health.
multinational specialty drugs company based in Laval, Quebec, Canada
- Reports this week
- 0
- Active events
- 1
- Connections
- 54
What's happening
Active this week
Earlier this month
-
Bausch Health is expanding its portfolio into several markets, including Slovakia, Bulgaria, Czech Republic, and Mexico.Some support1 report
-
Bausch Health made technology available in Australia in January 2026.Some support4 reports
-
Bausch Health made its technology available in Australia on January 1, 2026.Some support1 report
One to three months ago
-
Renaissance Technologies raised its position and increased holdings in Bausch Health stock, while also dropping its target price.Some support1 report
-
Johnson & Johnson, Carl Zeiss, and Bausch Health are major players in the vision care market, supported by supportive government initiatives.Some support2 reports3 developments inside
-
Bausch Health reports Vision Care revenue growth and anticipates key regulatory milestones for Elios.Some support1 report
Gone quiet
No new reports in 90+ days-
Bausch + Lomb, a subsidiary of Bausch Health, announced the resignation of board members Brett M. Icahn and Gary Hu.Some support2 reports
-
Michael Goettler, formerly of Viatris, was appointed to the Board of Directors of Bausch Health.Some support4 reports
-
Bausch Health is a major beneficiary of Trump tariffs, and Steven D. Miller resigned from the company’s board.Some support1 report
-
Bausch Health started using LinkedIn for company connection in July 2025.Speculative1 report
-
On July 11, 2025, Hologic was noted as Gen-Probe Incorporated. Companies including Bausch Health, Meridian Bioscience, and others are advancing testing technologies and treatment options.Some support1 report
-
Steven Lee was appointed Chief Accounting Officer of a company (implied Bausch Health) on July 11, 2025, where he had previously held senior roles.Some support1 report
-
Pfizer, Merck, Bausch Health, Viatris, and Santen Pharmaceutical are listed as key companies in glaucoma trials.Some support1 report
-
Bausch Health reported that international revenues grew due to growth in Canada, driven by its segment Salix.Some support3 reports1 development inside
-
Bausch Health reported that international revenues grew due to growth in Canada, driven by its segment Salix.Some support3 reports
-
Bausch Health extended a tender offer for shares of Durect.Some support1 report1 development inside
-
Acquisition between Durect and Bausch Health advances liver disease treatment.Well supported3 reports
-
Milestone payments tied to Bausch Health's sales in the US were announced on August 13, 2025.Some support1 report
-
Brett and Steven D. Miller resigned from the Bausch Health Board of Directors in August 2025.Some support1 report
-
Brett Icahn resigned from Bausch Health's board and built an economic interest in the company's shares.Some support1 report
-
Solta Medical became part of Bausch Health on September 5, 2025.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Bausch Health this week
News at the entities that move Bausch Health most-
Royal Bank of Canada Mentioned togetherRoyal Bank of Canada raised its holdings in the Dimensional US Sustainability Core 1 ETF on June 19, 2026.Moves Bausch Health
-
VISION CARE StructuralVISION CARE is providing free eye check-ups and spectacles in Mumbai.Moves Bausch Health
-
Jefferies Financial Group TransactionalApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Bausch Health
-
Renaissance Technologies TransactionalRenaissance Technologies holds a significant stake in Lite Strategy, Inc., whose stock trades on the Nasdaq exchange.Moves Bausch Health
-
board of directors StructuralThe Coldwater Area Chamber of Commerce is seeking nominations for its leadership body.Moves Bausch Health
-
Slovakia OperationalVertiv is expanding its manufacturing campus in Nové Mesto, Slovakia, with Paul Ryan leading EMEA operations.Moves Bausch Health
Connections
The 18 strongest of 54, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Salix Pharmaceuticals Structural
Bausch Health acquired Salix Pharmaceuticals, which operates as a subsidiary business unit.
-
Salix Structural
Salix is formally defined as a revenue segment within Bausch Health's business structure.
-
Brent Saunders Structural
Brent Saunders holds the leadership roles of Chairman and CEO of Bausch Health.
-
Durect (United States) Transactional
Bausch Health is actively acquiring Durect through a tender offer and subsequent acquisition.
-
Michael Goettler Structural
Michael Goettler served on Bausch Health's Board of Directors from July 2025 until his resignation in July 2026.
-
VISION CARE Structural
Vision Care operates as a business unit contributing to Bausch Health's overall revenue growth.
-
John Paulson Transactional
John Paulson or his associates acquired shares in Bausch Health through insider transactions.
-
Czech Republic Operational
Bausch Health is actively pursuing market presence and expanding its business portfolio within the Czech Republic.
Show all 18 connections
-
Kazakhstan Shared context
Bausch Health is forecasted to establish operational presence in Kazakhstan starting in October 2026.
-
Elios Operational
Bausch Health is actively involved in the regulatory development and milestones of Elios.
-
Jefferies Financial Group Transactional
Jefferies upgraded Bausch Health to a hold rating.
-
Renaissance Technologies Transactional
Renaissance Technologies increased its holdings in Bausch Health shares.
-
Carl Icahn Transactional
The relationship involved Carl Icahn building economic interest in Bausch Health shares and subsequently terminating an agreement.
-
Bulgaria Shared context
Bausch Health is expanding its business portfolio into the Bulgarian market.
-
Slovakia Operational
Bausch Health is actively expanding its business portfolio into the Slovakian market.
-
Royal Bank of Canada Mentioned together
Royal Bank of Canada monitors Bausch Health through market coverage and target price assessments.
-
Ohio Shared context
Bausch Health is observed within the economic context of Ohio.
-
board of directors Structural
Bausch Health utilizes the board of directors for governance and oversight.
History
Events by the month they beganSeptember 2026
4 events- Analyst upgrades and downgrades are affecting the stock prices of Bausch Health, Aflac, and Capri.
- Bausch Health is expanding its portfolio into several markets, including Slovakia, Bulgaria, Czech Republic, and Mexico.
- Bausch Health made technology available in Australia in January 2026.
- Bausch Health made its technology available in Australia on January 1, 2026.
August 2026
1 eventJuly 2026
1 eventShow 1 earlier month
June 2026
16 events- Johnson & Johnson, Carl Zeiss, and Bausch Health are major players in the vision care market, supported by supportive government initiatives.
- Bausch + Lomb, a subsidiary of Bausch Health, announced the resignation of board members Brett M. Icahn and Gary Hu.
- Michael Goettler, formerly of Viatris, was appointed to the Board of Directors of Bausch Health.
- Bausch Health is a major beneficiary of Trump tariffs, and Steven D. Miller resigned from the company’s board.
- Bausch Health started using LinkedIn for company connection in July 2025.
- On July 11, 2025, Hologic was noted as Gen-Probe Incorporated. Companies including Bausch Health, Meridian Bioscience, and others are advancing testing technologies and treatment options.
- Steven Lee was appointed Chief Accounting Officer of a company (implied Bausch Health) on July 11, 2025, where he had previously held senior roles.
- Pfizer, Merck, Bausch Health, Viatris, and Santen Pharmaceutical are listed as key companies in glaucoma trials.
- Bausch Health reported that international revenues grew due to growth in Canada, driven by its segment Salix.
- Bausch Health reported that international revenues grew due to growth in Canada, driven by its segment Salix.
- Bausch Health extended a tender offer for shares of Durect.
- Acquisition between Durect and Bausch Health advances liver disease treatment.
- Milestone payments tied to Bausch Health's sales in the US were announced on August 13, 2025.
- Brett and Steven D. Miller resigned from the Bausch Health Board of Directors in August 2025.
- Brett Icahn resigned from Bausch Health's board and built an economic interest in the company's shares.
- Solta Medical became part of Bausch Health on September 5, 2025.